Literature DB >> 2829959

Mortality in miners and millers of crocidolite in Western Australia.

B K Armstrong1, N H de Klerk, A W Musk, M S Hobbs.   

Abstract

It is known that 6505 men and 411 women were employed in the mining and milling of crocidolite at Wittenoom in the Pilbara region of Western Australia between 1943 and 1966. Employment was usually brief (median duration four months) and exposure intense (median estimated cumulative exposure 6 fibres/cc years). The vital status of 73% of the men and 58% of the women employed in the industry was known at 31 December 1980, providing 95 264 person-years of follow up with 820 deaths in men and 4914 person-years with 23 deaths in women. The standardised mortality ratio (SMR) for all causes in men was 1.53 (95% confidence interval 1.43 to 1.64). Statistically significant excess death rates were observed in men for neoplasms, particularly malignant mesothelioma (32 deaths), neoplasms of the trachea, bronchus, and lung (SMR 2.64), and neoplasms of the stomach (SMR 1.90); respiratory diseases, particularly pneumoconiosis (SMR 25.5); infections, particularly tuberculosis (SMR 4.09); mental disorders particularly alcoholism (SMR 4.87); digestive diseases, particularly peptic ulceration (SMR 2.46) and cirrhosis of the liver (SMR 3.94); and injuries and poisonings, particularly non-transport accidents (SMR 2.36). The excess mortality from pneumoconiosis, malignant mesothelioma, and respiratory cancers, but not stomach neoplasms, was dependent on time since first exposure and cumulative exposure. There was no increase in mortality from laryngeal cancer (SMR 1.09) or neoplasms other than those listed. The SMR for all causes in women was 1.47 (95% confidence interval 0.98-2.21) and for neoplasms 1.99; there was one death from malignant pleural mesothelioma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2829959      PMCID: PMC1007937          DOI: 10.1136/oem.45.1.5

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  19 in total

1.  Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.

Authors:  J C WAGNER; C A SLEGGS; P MARCHAND
Journal:  Br J Ind Med       Date:  1960-10

2.  Prevalence of radiographic asbestosis in crocidolite miners and millers at Wittenoom, Western Australia.

Authors:  W O Cookson; N H De Klerk; A W Musk; B K Armstrong; J J Glancy; M S Hobbs
Journal:  Br J Ind Med       Date:  1986-07

3.  Mortality experience of insulation workers in the United States and Canada, 1943--1976.

Authors:  I J Selikoff; E C Hammond; H Seidman
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

Review 4.  Pitfalls in epidemiological research. An examination of the asbestos literature.

Authors:  P E Enterline
Journal:  J Occup Med       Date:  1976-03

5.  Work and workers' responses at Wittenoom, 1943-1966.

Authors:  L Layman
Journal:  Community Health Stud       Date:  1983

6.  Cohort study of mortality of vermiculite miners exposed to tremolite.

Authors:  J C McDonald; A D McDonald; B Armstrong; P Sebastien
Journal:  Br J Ind Med       Date:  1986-07

7.  Asbestos-related mesothelioma: factors discriminating between pleural and peritoneal sites.

Authors:  K Browne; W J Smither
Journal:  Br J Ind Med       Date:  1983-05

8.  Latency of asbestos disease among insulation workers in the United States and Canada.

Authors:  I J Selikoff; E C Hammond; H Seidman
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

9.  Mortality of asbestos workers in England and Wales 1971-81.

Authors:  J T Hodgson; R D Jones
Journal:  Br J Ind Med       Date:  1986-03

10.  Asbestos and cancer: a cohort followed up to death.

Authors:  P E Enterline; J Hartley; V Henderson
Journal:  Br J Ind Med       Date:  1987-06
View more
  35 in total

1.  Correlation of ultra-low dose chest CT findings with physiologic measures of asbestosis.

Authors:  David Manners; Patrick Wong; Conor Murray; Joelin Teh; Yi Jin Kwok; Nick de Klerk; Helman Alfonso; Peter Franklin; Alison Reid; A W Bill Musk; Fraser J H Brims
Journal:  Eur Radiol       Date:  2017-01-12       Impact factor: 5.315

2.  The incidence of mesothelioma has not decreased for the last twenty years in Southeast region of Anatolia.

Authors:  A I Carkanat; A Abdurrahman; O Abakay; S Cengizhan; S H Selimoglu; A Senyigit
Journal:  Afr Health Sci       Date:  2011-09       Impact factor: 0.927

3.  Asbestos knowledge and awareness level in central part of Anatolia.

Authors:  Selma Metintas; Guntulu Ak; Filiz Bogar; Senay Yilmaz; Muzaffer Metintas
Journal:  Int J Occup Environ Health       Date:  2018-05-08

4.  Effects of asbestos and smoking on the levels and rates of change of lung function in a crocidolite exposed cohort in Western Australia.

Authors:  H S Alfonso; L Fritschi; N H de Klerk; N Olsen; J Sleith; A W Musk
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

5.  Prediction of mesothelioma, lung cancer, and asbestosis in former Wittenoom asbestos workers.

Authors:  A Rogers
Journal:  Br J Ind Med       Date:  1992-06

6.  Smoking, exposure to crocidolite, and the incidence of lung cancer and asbestosis.

Authors:  N H de Klerk; A W Musk; B K Armstrong; M S Hobbs
Journal:  Br J Ind Med       Date:  1991-06

7.  The effect of asbestosis on lung cancer risk beyond the dose related effect of asbestos alone.

Authors:  A Reid; N de Klerk; G L Ambrosini; N Olsen; S C Pang; G Berry; A W Musk
Journal:  Occup Environ Med       Date:  2005-12       Impact factor: 4.402

8.  Pleural lesions in crocidolite workers from Western Australia.

Authors:  G Hillerdal; A W Musk
Journal:  Br J Ind Med       Date:  1990-11

9.  A meta-analysis of the relation between cumulative exposure to asbestos and relative risk of lung cancer.

Authors:  T L Lash; E A Crouch; L C Green
Journal:  Occup Environ Med       Date:  1997-04       Impact factor: 4.402

10.  Silica, compensated silicosis, and lung cancer in Western Australian goldminers.

Authors:  N H de Klerk; A W Musk
Journal:  Occup Environ Med       Date:  1998-04       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.